Burns Matteson Capital Management, LLC Johnson & Johnson Transaction History

Burns Matteson Capital Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Dec 11, 2023	SELL	$154.35 - $166.11 $17,441 - $18,770	-113 Reduced 8.2%	1,265 $209 Million
Q1 2023 Dec 11, 2023	SELL	$151.05 - $180.26 $2,567 - $3,064	-17 Reduced 1.22%	1,378 $214 Million
Q4 2022 Dec 11, 2023	SELL	$160.2 - $179.79 $4,806 - $5,393	-30 Reduced 2.11%	1,395 $246 Million
Q3 2022 Dec 11, 2023	SELL	$161.33 - $179.52 $1,613 - $1,795	-10 Reduced 0.7%	1,425 $233 Million
Q2 2022 Dec 11, 2023	SELL	$168.19 - $186.01 $7,568 - $8,370	-45 Reduced 3.04%	1,435 $255 Million
Q1 2022 Dec 11, 2023	SELL	$158.14 - $179.59 $25,302 - $28,734	-160 Reduced 9.76%	1,480 $262 Million
Q2 2021 Dec 11, 2023	SELL	$159.48 - $171.07 $6,379 - $6,842	-40 Reduced 2.38%	1,640 $270 Million
Q1 2021 Dec 11, 2023	BUY	$153.07 - $170.48 $5,051 - $5,625	33 Added 2.0%	1,680 $276 Million
Q4 2020 Dec 11, 2023	BUY	$137.11 - $157.38 $225,820 - $259,204	1,647 New	1,647 $259 Million

4,239

1.7B

12.5M

10.3M

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $406B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

Get notified when there are updates to the investment portfolio of Burns Matteson Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Burns Matteson Capital Management, LLC with notifications on news.